JFL Life Sciences Limited (NSE:JFLLIFE)
India · Delayed Price · Currency is INR 10.35
+0.45 (4.55%)
At close: Sep 25, 2026
JFL Life Sciences Market Cap
JFL Life Sciences has a market cap or net worth of 341.5 million as of September 25, 2026. Its market cap has decreased by -20.38% in one year.
Market Cap
341.50M
Enterprise Value
544.17M
Revenue
1.31B
Ranking
n/a
PE Ratio
5.06
Stock Price
10.35
ChartMarket Cap Chart
Since September 8, 2022, JFL Life Sciences's market cap has decreased from 731.40M to 341.50M, a decrease of -53.31%. That is a compound annual growth rate of -17.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 341.50M | -17.20% |
| Dec 31, 2025 | 412.44M | -59.35% |
| Dec 30, 2024 | 1.01B | 122.29% |
| Dec 29, 2023 | 456.44M | 22.06% |
| Dec 30, 2022 | 373.95M | -48.87% |
| Sep 8, 2022 | 731.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biofil Chemicals and Pharmaceuticals | 522.06M |
| Mangalam Drugs & Organics | 504.92M |
| Vista Pharmaceuticals | 401.32M |
| Rajnish Wellness | 395.99M |
| Panjon | 377.62M |
| Sandu Pharmaceuticals | 357.46M |
| Murae Organisor | 353.20M |
| Gujarat Terce Laboratories | 280.64M |